ASIA-LINK Medicinal-Chemistry University of Regensburg

<body> <p>WELCOME to ASIA-LINK - MEDICINAL-CHEMISTRY UNIVERSITY OF REGENSBURG:<BR><BR>Directlink <A HREF="http://www.remoteconsulting.net/medchem/asialink/en/index.asp">http://www.remoteconsulting.net/medchem/asialink/en/index.asp</A><BR><BR> Human health is of central importance for all societies. Therefore, education and research in the field of medicinal chemistry has a long history both in Europe and Asia, whereby differences in methods and philosophy clearly exist. The aim of the project Asia-Link (Asia Link) Medicinal Chemistry is to specifically strengthen the collaboration in higher education and research in modern drug discovery between the EU partners and the Asian participants. To reach the aim young researchers from the Asian partners will receive training and participate in research projects at the European institutions, while young European researchers will gain knowledge on traditional medicine and plants at the Asian partners. Stipends to support travel and living expenses are available from the program.<BR><BR> <B>Contact:</B><BR><BR> Prof. Dr. Burkhard König<BR> Div. of Organic Chemistry I University of Regensburg<BR> Universitätsstr. 31<BR> D–93052 Regensburg / Germany<BR> Tel.: +49 (0) 941 943-4575<BR> Fax.: +49 (0) 941 943-1717<BR> <BR><BR> Our Project Partners are:<BR> University of Ulm, Germany<BR> University of HoChiMinh City, Vietnam<BR> University of Hue, Vietnam<BR> University of Shanghai, China<BR> University of Dublin, Ireland<BR> KAAD, Germany </p> Söùc khoûe con ngöôøi laø moät vaán ñeà heát söùc quan troïng trong taát caû moïi xaõ hoäi. Vì theá giaùo duïc vaø nghieân cöùu trong lónh vöïc hoaù döôïc ñaõ coù moät lòch söû laâu ñôøi ôû caû Chaâu AÂu laãn Chaâu AÙ, tuy nhieân roõ raøng laø coù nhöõng khaùc bieät veà phöông phaùp vaø trieát lyù trong lónh vöïc naøy ôû hai chaâu luïc. Muïc ñích cuûa Döï aùn <A HREF="http://www.remoteconsulting.net/medchem/asialink/en/index.asp">Asia Link-Medicinal Chemistry</A> (Döï aùn Keát noái vôùi AÙ Chaâu trong Lónh vöïc Hoaù Döôïc) laø nhaèm taêng cöôøng maïnh meõ söï hôïp taùc giöõa caùc thaønh vieân cuûa Coäng Ñoàng Chaâu AÂu vaø caùc thaønh vieân Chaâu AÙ trong lónh vöïc giaùo duïc sau ñaïi hoïc vaø nghieân cöùu ñeå khaùm phaù ra caùc loaïi thuoác môùi. Ñeå ñaït ñöôïc muïc ñích naøy, caùc nhaø nghieân cöùu treû cuûa Chaâu AÙ seõ ñöôïc huaán luyeän vaø tham gia caùc döï aùn nghieân cöùu ôû caùc tröôøng ñaïi hoïc hay vieän nghieân cöùu ôû Chaâu AÂu vaø caùc nhaø nghieân cöùu treû Chaâu AÂu seõ coù ñöôïc nhöõng kieán thöùc veà y hoïc truyeàn thoáng vaø caây thuoác töø caùc nöôùc thaønh vieân Chaâu AÙ. Chi phí cho vieäc aên ôû vaø ñi laïi do chöông trình naøy taøi trôï.<BR><BR> <BR><BR> For our chinese user: Please use the following link <A HREF="http://www.medicinal-chemistry.de/asialink/Asia-Link-Chinese.doc">Chinese Word-Document</A><BR><BR> This Site is powered by AFAIRA Business Consulting <a href="http://www.afaira.com/AF/de/index.asp" target="_blank">www.afaira.com</a><br><br> Human health is a central issue for every society. All European member states and the European Union itself annually allocates large budgets to education and research in medicinal chemistry and drug discovery to improve the quality of life by better treatment and diagnosis of diseases. However, modern drug discovery research has become a multidisciplinary and competitive endeavour. Only global expert alliances are able to successfully compete in the race to find new and better drugs. <BR><BR> While intensive collaborations in the field within Europe and the U.S.A. exist due to the training that many researchers receive at the graduate or postdoctoral level in the respective countries before entering pharmaceutical industry or academia in their home countries, rather few interactions with Asian countries have been established. This is particular true for countries such as China and Vietnam, which due to their rich cultural heritage offer huge opportunities for Europe to gain valuable knowledge for health care and drug development. In the Asia Link Medicinal Chemistry programme, such collaboration will be strengthened, inter alia by common teaching activities and research projects with joint PhD supervision by two partners. This will create an advantage for the development of research and education in Medicinal Chemistry in the European Community. The different methods and philosophies in medicinal and pharmaceutical research may make collaboration exceedingly interesting and fruitful. </body>